Helping our Clients Turn Hope into Reality

Andelyn Biosciences is pioneering solutions that turn hope into reality as a biopharmaceutical CDMO. With 20+ years of experience manufacturing viral vectors, Andelyn’s scientific expertise for development and characterization has led to GMP material being produced for over 75+ worldwide clinical trials and 400+ cGMP clinical batches. Advanced quality systems, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.
We support clients through all phases of development and commercialization.
Our Patients Define Us
The name “Andelyn” was chosen to pay tribute to two brave young patients that participated in pivotal clinical trials that make today’s gene therapies possible.
Updates from Andelyn
Media Release
January 13, 2022
COLUMBUS, OH, January 13, 2022 – Andelyn Biosciences, a pioneering cell and gene therapy CDMO born out of Nationwide Children’s Hospital, today...
November 22, 2021
Andelyn Biosciences has set its sights on Dublin for one of two new labs for the gene therapy company.
November 11, 2021
Andelyn Biosciences has established a unique network of industry experts across the entire development and commercialization spectrum. In addition to...
October 22, 2021
Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...
Our Employees Fuel Our Success
Andelyn is made up of an Inspired, Innovative and Compassionate team that contribute towards a rich company culture. We are always looking for great people who want to do great things.